Managed Services Contract – Medical Biochemistry & Immunology

A Modification Notice
by CARDIFF AND VALE UNIVERSITY HEALTH BOARD

Source
Find a Tender
Type
Contract (Services)
Duration
5 year
Value
£100M
Sector
INDUSTRIAL
Published
21 Mar 2025
Delivery
To 23 Feb 2030 (est.)
Deadline
n/a

Related Terms

Location

Cardiff and Vale of Glamorgan: Cardiff and Vale University Health Board

Geochart for 1 buyers and 1 suppliers

Description

Total Quantity or Scope

Tender Process timing - To ensure that the appropriate level of detail and due diligence is applied to any future tender it is has been established that a five-year extension to the current contract would be necessary for the following reasons; - The need to provide a safe sustainable Clinical service during the tender process. The Clinical risk of not having an operational Medical Biochemistry and Immunology service within Cardiff and Vale is significant as the laboratory is involved in 70% of all Clinical decisions – around 90% of the work undertaken within the department requires a 2 hour turnaround from time of receipt to reporting of the result which can only be achieved with an onsite service supported by hardware and the LIMS system. - 12 months to write and refine the tender specification – there is currently no specification written other than the one issued around 2007 – this requires time to ensure all key points are covered - 24-36 Months to go through the tender process including viewing potential options open to us to ensure an informed choice is made. - 12-24 Months Implementation – this would include phasing out the current equipment following validation and verification of any new platforms - some assays may require significant patient rebase lining which means dual running to evaluate any change in results on a personal patient basis - during this period a contract will still be required with Abbott diagnostics. - Tender processes – there is evidence from other sites within the UK including legal precedence that show the above is a realistic timeline. End of life-cycle equipment - The current equipment provided under the managed service contract with Abbott including Alinity analysers and associated automation (sample tracking and movement system) is 8 years old and needs replacing. A five-year contract could achieve this cost effectively, but any lesser period would place huge financial pressures on the HB in duplicative costs and may not be achievable. In the short term, not changing the aging equipment now and attempting to run it for a further 2-3 years to undertake a procurement exercise (notwithstanding the technical/resource limitations) would create a significant patient risk as the analysers down time which is likely to increase, will have a detrimental effect on the department’s ability to turnaround the majority of work within the required 2 hours’ time window, this places patients at risk by not being able provide laboratory results to make a clinical decision. Accordingly, the indication is that a period of less than five years is not economically viable to replace the current system. - There is also an indication that the automation is nearing its end of life, this is evidenced by the increased down time of individual components on the tracking system and time taken to obtain parts, life expectancy of this equipment is around 8 years although that is not a hard end point as with the LIMS, rather it is an unknown risk that could materialise or escalate in severity over time. Abbott Diagnostics are no longer contracting their track system to Inpeco and going forward would not be able to hold the risk under the MSC due to this contracting change. - As indicated 8 years is the usual life cycle of both analytical and tracking systems, although the equipment is still fully functional down time will increase and for the track will take longer to obtain, this increased downtime will seriously affect our ability to meet the 2 hours’ time window for the return clinical results required to treat patients

Award Detail

1 Abbott Laboratories (Maidenhead)
  • Managed Services Contract – Medical Biochemistry & Immunology
  • Reference: 010567-2025-cav-dco (24-25) 142 cr46-1
  • Value: £99,652,746

CPV Codes

  • 71900000 - Laboratory services

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** It is considered that the requirements of 72(1)(b) are met in relation to the extension which has become necessary such that a change of contractor cannot be made for economic or technical reasons such as requirements of interchangeability or interoperability with existing equipment, services or installations procured under the initial procurement, or (ii)would cause significant inconvenience or substantial duplication of costs. The technical and economic reasons are set out below Technical issues involve: - LIMS System - Changing the LIMS is a major undertaking at any time and to do this as the same time as changing our major equipment platforms would not have allowed us to guarantee a patient safe service – the LIMS change cannot be delayed because of infrastructure issues which means the supplier cannot support the current system after the spring of 2026 giving a firm end point on the current system. - The original contract award commenced in 2022 but did not progress due to various issues so was re-awarded in 2023 which meant all the work undertaken in 2022 was lost and we have needed to enter into an accelerated period of testing and evaluation due to the firm deadline of the spring of 2026, this is taking a significant amount of departmental resources to the point that key staff are having to undertake overtime to complete the work, these are the same individuals required to contribute to the tender specification. - With the accelerated process of acceptance testing the plan to go live by early 2026 when there will be a further period of testing minor defects are repaired. - Analytical Equipment - To currently change the current analytical system to a new unknown system would place significant pressure on the team who are currently fully engaged in the testing and validation of the new Laboratory Information System – to implement a new system would require full technical and clinical evaluation against the current equipment for all assays including: - Full Verification and validation of each assay - Re-baselining patient on specific assays - Full linearity checking of each assay - Carry over and cross over experiences - Technical retraining of the staff during this period of high pressure - Experience has shown this can take up to 12 months of several senior staff full time – these are the same staff currently testing the laboratory information system while simple replacement to the same analytical system only required simple correlation checking as all other parameters have been checked (WA Ref:148722)

Reference

  • ocds-h6vhtk-04cc57
  • FTS 010567-2025

Domains